IRIS
SARACENO, ROSITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.862
AS - Asia 1.614
EU - Europa 1.612
SA - Sud America 225
AF - Africa 34
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.370
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.815
SG - Singapore 616
CN - Cina 511
DE - Germania 228
RU - Federazione Russa 218
IT - Italia 214
UA - Ucraina 213
BR - Brasile 179
FR - Francia 151
HK - Hong Kong 139
IE - Irlanda 135
SE - Svezia 116
VN - Vietnam 101
GB - Regno Unito 98
FI - Finlandia 76
PL - Polonia 58
IN - India 52
KR - Corea 52
JP - Giappone 36
CA - Canada 30
AR - Argentina 17
AU - Australia 17
BD - Bangladesh 16
ES - Italia 16
AE - Emirati Arabi Uniti 13
CO - Colombia 13
EG - Egitto 12
NL - Olanda 12
SK - Slovacchia (Repubblica Slovacca) 12
ZA - Sudafrica 10
CH - Svizzera 9
KG - Kirghizistan 9
PH - Filippine 9
RO - Romania 9
TR - Turchia 9
GR - Grecia 8
IR - Iran 8
MX - Messico 8
PY - Paraguay 8
BE - Belgio 7
AT - Austria 6
IQ - Iraq 6
MA - Marocco 6
UZ - Uzbekistan 6
LV - Lettonia 5
PK - Pakistan 5
RS - Serbia 5
TW - Taiwan 5
CZ - Repubblica Ceca 4
LT - Lituania 4
PT - Portogallo 4
CL - Cile 3
EU - Europa 3
ID - Indonesia 3
MY - Malesia 3
OM - Oman 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EC - Ecuador 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SN - Senegal 2
VE - Venezuela 2
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 18.370
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.102
Houston 3.739
Wilmington 3.344
Fairfield 454
Singapore 388
Ann Arbor 348
Chandler 320
Ashburn 298
Jacksonville 185
San Jose 172
Beijing 167
Cambridge 166
Seattle 161
Dublin 135
Hong Kong 133
New York 112
Medford 109
Zhengzhou 92
Dearborn 90
Rome 71
The Dalles 66
Los Angeles 53
Lawrence 50
Dallas 49
Santa Clara 49
Kraków 35
Shanghai 34
Moscow 33
Ho Chi Minh City 32
Boardman 31
Lauterbourg 31
Tokyo 31
Council Bluffs 25
Helsinki 25
Menlo Park 25
Hanoi 24
Buffalo 23
San Diego 21
São Paulo 20
Redondo Beach 18
Munich 17
Mülheim 17
Hefei 16
Norwalk 16
Orem 16
Hangzhou 14
Nanjing 14
Redwood City 13
London 12
Warsaw 12
Brooklyn 11
Chennai 11
Dubai 11
Guangzhou 11
Milan 11
Detroit 10
Montreal 10
Da Nang 9
Denver 8
Kunming 8
Paris 8
Stockholm 8
Toronto 8
Frankfurt am Main 7
Haiphong 7
Nanchang 7
Palo Alto 7
Phoenix 7
Redmond 7
San Mateo 7
Brussels 6
Chicago 6
Columbus 6
Draper 6
Johannesburg 6
Madrid 6
Manchester 6
Poznan 6
Salt Lake City 6
Asunción 5
Bern 5
Bolzano 5
Dhaka 5
Fuzhou 5
Melbourne 5
Mountain View 5
Nuremberg 5
Riga 5
Trento 5
Turku 5
University Park 5
Verona 5
Wuhan 5
Amsterdam 4
Ankara 4
Auburn Hills 4
Baghdad 4
Bengaluru 4
Cairo 4
Carinaro 4
Totale 15.733
Salva come PNG Salva come JPEG
Nome #
Crusted scabies in a liver transplant patient mimicking rupioid psoriasis 1.396
Efficacy and safety of infliximab in psoriatic patients over the age of 65 546
Atopic dermatitis and dental manifestations 543
Topical lactoferrin can improve stable psoriatic plaque 492
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers 486
Apremilast for the treatment of psoriasis. 477
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 473
New topical treatments for psoriasis 456
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 455
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 454
Profile of certolizumab and its potential in the treatment of psoriatic arthritis 453
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 453
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis 450
Oral lichen planus: therapy and phenotype 447
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 446
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 440
Role of IL-23 in the pathogenesis of psoriasis: A novel potential therapeutic target? 439
The significance of the development of antinuclear antibodies during infliximab treatment 433
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 422
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment 412
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 411
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 410
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 403
Erysipeloid cutaneous metastasis from bladder carcinoma 400
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 394
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 394
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 391
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome 389
Prevalence and management of panic attacks during infliximab infusion in psoriatic patients 376
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 369
Does metabolic syndrome influence psoriasis? 364
Serum Protein Profile Changes in Psoriatic Patients Undergoing Treatment With Infliximab 364
The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term study 357
Tofacitinib for the treatment of moderate-to-severe psoriasis 350
Why 3 mg/kg instead of 5 mg/kg of infliximab should work in psoriatic arthritis? 324
Safety evaluation of apremilast for the treatment of psoriasis 319
A European perspective on the challenges of managing psoriasis 224
Oral lichen planus: Therapy and phenotype 208
308 nm monochromatic excimer light in the treatment of psoriasis 201
Different applications of monochromatic excimer light in skin diseases 187
Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides 173
Treatment of folliculitis with monochromatic excimer light (308 nm). 165
Type III juvenile pityriasis rubra pilaris: A successful treatment with infliximab [12] 157
Aphthous, coeliac disease and other dental disorders in childhood 157
Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab. 152
Randomized, within-patient, clinical trial comparing fluorine-synthetic fiber socks with standard cotton socks in improving plantar pustulosis 150
Nanomedicine in dermatology: Benefits and emerging applications 144
Comparison of a novel treatment protocol with oral fluconazole vs probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 in the treatment of recurrent vulvovaginal candidiasis 129
Clinical severity instruments 116
Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: A report of two cases 110
Keratosis punctata palmoplantaris and malignancies: case report 83
Apheresis in the treatment of recalcitrant atopic dermatitis: Case series and review of the literature 65
Totale 18.609
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.295
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.295
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021127 0 0 0 0 0 0 0 0 0 0 104 23
2021/2022533 32 59 41 34 14 54 23 21 40 56 28 131
2022/2023815 70 63 37 119 87 153 56 48 98 11 39 34
2023/2024345 34 8 37 18 26 104 21 13 2 7 10 65
2024/2025980 47 193 106 77 34 58 102 36 74 96 98 59
2025/20261.776 166 95 239 184 196 67 261 196 205 149 18 0
Totale 18.609